Rigel Pharmaceuticals, Inc. (RIGL) Revenue Growth
Rigel Pharmaceuticals, Inc. (RIGL) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | -78.00% |
| 2018-12-31 | 892.62% |
| 2019-12-31 | 33.20% |
| 2020-12-31 | 83.21% |
| 2021-12-31 | 37.39% |
| 2022-12-31 | -19.43% |
| 2023-12-31 | -2.79% |
| 2024-12-31 | 53.38% |
| 2025-12-31 | 64.15% |
How RIGL compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| TXMD | TherapeuticsMD Inc. | 71.61% |
| AKBA | Akebia Therapeutics Inc. | 47.46% |
| ARRY | Array Technologies Inc. | 40.22% |
| IONS | Ionis Pharmaceuticals Inc. | 33.83% |
| MOH | Molina Healthcare Inc | 11.75% |
These are five companies in the same sector as RIGL with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Rigel Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("RIGL", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RIGL | $49.42 | +4.04% | 0.18M |
| 3 | ||||
| 4 | ||||
| 5 |